In 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was associated with several cases of pneumonia. The rapid spread of this virus resulted in...
COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of the health records of 48...
A detailed review article describing coronavirus disease 2019 (COVID-19)-related coagulopathy was recently published in the journal. nature review immunology. perspective: Understanding COVID-19-related coagulopathyImage Credit: NIAID Background...
In patients with COVID-19, obesity is the most associated factor in the development of endothelial dysfunction, a condition in which blood vessels are unable to contract...
A potentially game-changing treatment for people with or at risk of blood clots has been found to be effective by an international team of researchers led...
Intravenous immunoglobulin (IVIG) helped resolve the effects of vaccine-induced thrombotic thrombocytopenia (VITT) in 3 patients after receiving the AstraZeneca COVID-19 vaccine. After high doses of IVIG,...
Recent Comments